Orthofix International | OFIX - Gross Profit On Sales


Orthofix International reported $545.88M in Gross Profit on Sales for its fiscal quarter ending in December of 2024.





Gross Profit On Sales Change Date
Accuray USD 41.89M 7.42M Dec/2024
AngioDynamics USD 38.86M 1.05M Feb/2025
Artivion USD 61.01M 2.32M Sep/2024
AtriCure USD 105.34M 4M Dec/2025
Dexcom USD 792.7M 61.3M Dec/2025
EDAP TMS EUR 5.97M 850K Sep/2025
Globus Medical USD 535.95M 49.28M Dec/2025
Hologic USD 586.4M 2.9M Dec/2025
Inogen USD 41.34M 1.39M Sep/2024
Insulet USD 568.6M 58.5M Dec/2025
Integra LifeSciences USD 217.1M 10.11M Dec/2025
J&J USD 16.6B 118M Dec/2025
Medtronic USD 5.41B 27M Dec/2025
Mesa Laboratories USD 39.75M 4.3M Dec/2024
Orthofix International USD 545.88M 410.83M Dec/2024
Smith & Nephew USD 2.09B 117M Dec/2025
STAAR Surgical USD 43.74M 34.13M Dec/2025
Stryker USD 4.49B 633M Dec/2025
Surmodics USD -11.54M 3.99M Sep/2024
Tandem Diabetes Care USD 167.46M 33.17M Dec/2025
Teleflex USD 307.45M 144.2M Dec/2025
Veracyte USD 101.97M 10.69M Dec/2025
Zimmer Biomet Holdings USD 1.27B 8.1M Dec/2025